Large B-cell lymphoma (LBCL)

Clinical trials for Large B-cell lymphoma (LBCL) explained in plain language.

Never miss a new study

Get alerted when new Large B-cell lymphoma (LBCL) trials appear

Sign up with your email to follow new studies for Large B-cell lymphoma (LBCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 5 Not yet recruiting 7 Not yet finished but already full! 1

Double-Targeting CAR-T cells aim to outsmart lymphoma relapse

Disease control Ongoing

This phase 2 trial tests a new type of CAR-T cell therapy that targets two proteins (CD19 and CD22) on lymphoma cells, aiming to prevent the cancer from escaping treatment. It involves 100 adults with relapsed or refractory large B-cell lymphoma who have not responded to standard…

Matched conditions: LARGE B-CELL LYMPHOMA (LBCL)

Phase 2 • Sponsor: Beijing Tongren Hospital • Aim: Disease control

Last updated Jun 27, 2026 12:23 UTC

Large B-cell lymphoma (LBCL)

Get alerted when new Large B-cell lymphoma (LBCL) trials appear

Double-Targeting CAR-T cells aim to outsmart lymphoma relapse